Timothy Rolph

Chief Scientific Officer at Akero Therapeutics - South San Francisco, CA, US

Timothy Rolph's Colleagues at Akero Therapeutics
John CEP

Vice President Finance and Controller

Contact John CEP

Kitty Yale

EVP and Chief Development Officer

Contact Kitty Yale

Brittany De Temple

director of clinical operations and program management

Contact Brittany De Temple

Yuan Xu

Independent Board Director

Contact Yuan Xu

Kimberly Barrett

Associate Director, Clinical Data Management

Contact Kimberly Barrett

View All Timothy Rolph's Colleagues
Timothy Rolph's Contact Details
HQ
650-487-6488
Location
Brookline, Massachusetts
Company
Akero Therapeutics
Timothy Rolph's Company Details
Akero Therapeutics logo, Akero Therapeutics contact details

Akero Therapeutics

South San Francisco, CA, US • 20 - 49 Employees
BioTech/Drugs

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

N/A
Details about Akero Therapeutics
Frequently Asked Questions about Timothy Rolph
Timothy Rolph currently works for Akero Therapeutics.
Timothy Rolph's role at Akero Therapeutics is Chief Scientific Officer.
Timothy Rolph's email address is ***@akerotx.com. To view Timothy Rolph's full email address, please signup to ConnectPlex.
Timothy Rolph works in the BioTech/Drugs industry.
Timothy Rolph's colleagues at Akero Therapeutics are Louben Dorval, John CEP, Yasmine CPA, Kitty Yale, Brittany De Temple, Yuan Xu, Kimberly Barrett and others.
Timothy Rolph's phone number is 650-487-6488
See more information about Timothy Rolph